WFDC2 and COVID-19: Hence, we conducted a clinical study to further characterize the alterations of serum HE4 level in critically ill, severe, and mild COVID-19 cohorts having comparable demographical parameters and applied a bacterial sepsis group as ICU controls to match their laboratory parameters (Table 1).